AlphaYouOA
Insider selling
Orbimed Advisors Llc sold $39M of Enliven Therapeutics, Inc. (ELVN) stock
Orbimed Advisors Llc, 10% owner of Enliven Therapeutics, Inc. (ELVN), sold 860,123 shares of ELVN stock worth $39M, per an SEC Form 4 filed Jun 24, 2026.
It was an open-market sale.
The trade happened on Jun 22, 2026, 2 days before it was made public.
ELVN has moved +6.3% since the trade date, from $45.96 to $48.87 (Sep 21, 2026 close).
- Traded
- Jun 22, 2026
- Disclosed
- Jun 24, 2026
- Filing delay
- 2 days
- Price since
- +6.3%
- Role
- 10% owner
- Source
- SEC Form 4
More ELVN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.